Hippocratic AI has raised $126 million in a Series C funding round at a $3.5 billion valuation, bringing its total funding to $404 million. The round was led by Avenir Growth and included participation from CapitalG, General Catalyst, Andreessen Horowitz, Kleiner Perkins, Premji Invest, Universal Health Services, Cincinnati Children’s Hospital, WellSpan Health, and several prominent investors. The company, which develops generative AI for nondiagnostic healthcare tasks, plans to use the funds to accelerate product innovation—including its Polaris Safety Constellation Architecture—expand global deployments, and pursue strategic mergers and acquisitions. Hippocratic AI’s AI agents are designed to support administrative and operational workflows such as medication onboarding, policy Q&A, EHR assistance, and patient follow-up calls, emphasizing safety and scalability across the healthcare ecosystem.
CEO Munjal Shah said the funding will allow Hippocratic AI to “touch more lives” while upholding its core values of “do no harm” and “patients first.” The company’s rapid growth has been marked by a steady progression of funding rounds, beginning with $50 million in seed capital in 2023 and a $141 million Series B earlier in 2025. Recent partnerships with Fivetran, Eraas Health, and University Hospitals have expanded its footprint across data infrastructure, climate-health risk monitoring, and patient engagement. Hippocratic AI also achieved SOC 2 Type II certification, underscoring its commitment to data security and compliance—key factors in its emergence as a leading provider of safe, generative AI systems in healthcare.